IMR

IMRICOR CDI FORUS [IMR]
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Healthcare · ASX Small Cap
$1.7000 -1.7%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when IMR triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IMR — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Strong cash runway (9 quarters)
  • Very high P/S ratio (2030.0x)
  • Revenue in sharp decline (-83%)
  • EPS estimates revised upward (+10pts)
  • Capital raise activity (1 events)
  • CANSLIM I: Institutional ownership (16%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 24% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.33%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -83% — the top line is shrinking
Ask Scout AI about IMR
"What's driving IMR today?" "How does IMR compare to peers?" "Key risks for IMR?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Imricor Submits All Remaining 510(k) Devices to FDA
NONE Notification regarding unquoted securities - IMR
NONE Cleansing Notice
Announcement tone +3pts

Recent ASX Announcements

2026-07-19 Imricor Submits All Remaining 510(k) Devices to FDA PRICE SENSITIVE
2026-07-14 Notification regarding unquoted securities - IMR
2026-07-13 Cleansing Notice
2026-07-13 Application for quotation of securities - IMR
2026-07-01 Imricor Receives FDA Pediatric Clearances for iMR Device PRICE SENSITIVE

Key Metrics

$593.4M
Market Cap
399K
Avg Volume
1.2x
Vol Ratio
$1.15 — $2.25
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-1221.3%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 77%
LLeader vs LaggardlaggardRS: -9
IInstitutional SponsorshippassInst: 16%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:IMR vs PIQIMR vs SLDIMR vs ADR
Scout Pro — Deeper Analysis for IMR
Try Pro free for 30 days
Share this analysis

Track IMR and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required